RSS

reimbursement

Swedish Orphan Biovitrum (Sobi) — a pharmaceutical company that specialises in rare diseases — has secured NHS England reimbursement for its medicine for the management of urea cycle disorders (UCDs), Ravicti (glycerol phenylbutyrate). more

News